Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine TAPB+RSB and anesthesia depth in elderly colorectal cancer surgery
ChiCTR2500109317Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Kunming Medical University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in colorectal cancer (CRC) (3 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoints: S-100β, NSE and 2 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500109317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109317.